MEETINGS - Technomic Publishing will hold the following seminars (US) March - April 1998:
This article was originally published in Clinica
Executive Summary
Technomic Publishing will hold two seminars in Boston on the science and technology of designing medical equipment. Designing Neurovascular Devices, on March 30-31, will discuss topics such as applying the principles of neurovascular anatomy and physiology to the design of medical devices; understanding how diseases and injuries affect the neurovascular system; and identifying the regulatory requirements that apply to neurovascular products. Designing Cardiovascular Devices, on April 1-3, will cover the latest advances in cardiovascular devices and current pharmacological and surgical interventions. Contact Technomic in the US for more details. Tel: +1 717 291 5609. Fax: +1 717 295 9637.
You may also be interested in...
Finance Watch: Silverback, Kinnate, Sigilon Launch December’s First IPOs
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
BioCryst’s Oral Option To Take On Injectables In HAE Prophylaxis Market
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
STRENGTH Results May Weaken Chances For Omega-3 Fatty Acid Heart Health Claims
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: